Trial transcripts, day by day.

Opening statements

The court’s preliminary instructions and both sides’ opening roadmaps remain indexed separately from witness evidence.

Trial Day 2

Witnesses: Patrick Clancy (continued); Angela Krause; Saria Shelgren; Patrick Clancy continued through cross-examination and follow-up.

The Commonwealth developed the January 24 CVS and ThreeV errand chronology through Patrick's testimony, CVS transaction evidence, and ThreeV telephone/order evidence. The record also expanded family, treatment, medication, diary, and communication evidence on cross-examination. Lindsay-authored or reported symptoms and medication effects remain attributed self-report rather than independent proof or causation; counsel's questions are not evidence unless adopted by a witness.

Source note: The working transcript's call-out identifies “Saria Sweeney,” while the sworn witness identified herself as Saria Shelgren; the sworn identification controls absent a stronger source. Exact exhibit numbering and embedded broadcaster material remain source-normalization items.

Trial Day 3

Witnesses: Officer Stephen Hall; Officer Brian Josephine; PJ Hussey; Loring Nudd; Keith Nette; Patrick Dwyer; Jennifer Stratton; Robert Costanzo; Daniel Dougherty; Vincent Cahill.

First-responder and emergency witnesses described the initial Duxbury response, backyard and basement observations, child assessment and resuscitation, emergency treatment and transport, and Lindsay's backyard assessment and transport. Responder observations remain witness-specific; emergency treatment steps and artifacts are distinct from pre-treatment injuries, later forensic conclusions, psychiatric diagnosis, and proof of intent.

Source note: The working transcript is secondary and uses occasional generic labels. Overlapping responder accounts remain separately attributed, and final exhibit mapping remains subject to stronger-source normalization.

Trial Day 4

Witnesses: Mark Anthony Maffeo; Dr. Mark Joseph Tenerowicz; Dr. Benjamin Kaufman; Melissa Arcadipane.

The Commonwealth presented custodial and hospital observations, pediatric emergency treatment for Dawson and Callan, and specimen intake and preservation evidence. Early sedation or unconsciousness, emergency cardiac care, return of circulation, airway management, injury photographs, and blood/urine preservation are kept within each witness's role. Received medical history is distinct from personal observation, and emergency-care testimony is not silently converted into later forensic cause-of-death or subjective-intent findings.

Source note: Exact exhibit numbers for the medical-record binder and early injury photographs, plus some speaker labels, remain normalization items. Admission of certified records does not make every statement inside those records independently established.

Trial Day 5

Witnesses: Dr. Michael Snyder; Dr. Andrew Capraro; Dr. David Casavant; Kelly McDonough; Rose Stoffers; Rachelle Amedee; Meghan Collins; Dr. Sejal Shah; Dr. Jhilam Biswas; Robert Flynn; Mark Farioli; John Santos; Cory Melo.

The day combined pediatric emergency and hospital evidence, Lindsay's critical-care recovery and psychiatric-consult/capacity evidence, scene and investigative testimony, and defendant-authored writings. ICU confusion and delirium observations, Dr. Shah's January 29 delirium assessment and later resolution, subsequent psychiatric encounters, and Lindsay-authored descriptions of sleep, anxiety, depression, appetite, medication concerns, guilt, work, and family remain encounter- and source-specific. Later ICU delirium is not back-projected to January 24.

Medication source rule: prescribed ≠ dispensed ≠ possessed ≠ taken ≠ taken as directed ≠ therapeutically exposed ≠ caused an effect.

Source note: Exact exhibit numbering, some transcript labels, and pediatric treating-role attribution remain normalization items. Lindsay-reported symptoms remain self-report unless independently established.

Trial Day 6

Separate the January 25 kitchen-cabinet medication recovery from the February 6 CVS-bag delivery; preserve sample-specific blood confirmation and screening/confirmation distinctions; the knife and exercise bands produced no comparison-value ridge detail; toxicology screening, quantitation, child-specific postmortem results, and bloodstain-pattern testimony remain distinct evidence classes.

Source note: Crook exhibit-number normalization around post-186 slide admissions.

Trial Day 7

Witnesses: Eitan Negri; Nicholas Roberts; Justin Brower; Katarina Stashyn; Elaine Rossi, with agreed drug-name, DNA, and NMS stipulations.

The Commonwealth presented Lindsay's wrist-injury treatment, MSP and reference-laboratory toxicology evidence, DNA findings and stipulations, and nanny observations. Injury treatment does not establish subjective intent. Toxicology results remain specimen-, assay-, and quantitation-specific and do not establish dose, timing, impairment, or causation beyond the laboratory evidence. DNA findings remain sample-specific; inclusion or contact does not establish who placed or used an item, when, or by what mechanism. Rossi's observations remain separate from Lindsay's reported symptoms.

Source note: The transcript introduction says Jonathan Brower, while the sworn witness identifies himself as Justin Brower; the sworn identification controls absent a stronger source. Exact exhibit/sample mapping around Exhibits 205–212 remains a source-normalization item.

Trial Day 8

Source material has been recovered. Consequential recovered wording remains withheld until it is checked against the audiovisual record or another stronger source.

Trial Day 9

Witnesses: Kimberlee Hardy; Sarah Carney; Dr. Alia Goodheart; Dr. Jennifer Tufts. Goodheart’s McLean treatment observations and Tufts’s longitudinal prescribing/supportive-care testimony remain source-specific. Screening response ≠ diagnosis; prescribed ≠ taken; patient-reported effect ≠ independently established causation; no observed psychosis at one encounter ≠ proof of absence elsewhere.

Trial Day 10

Witnesses: Dr. Jennifer Tufts recalled; Julie Paul. Encounter-specific Jan. 23 observations, PRN/daily/alternative medication instructions, pill-count arithmetic, South Shore treatment, patient-reported effects, and planned provider transition remain separate propositions.

Source note: Jan. 16 amitriptyline search-versus-appointment/order sequencing unresolved.

Trial Day 11

Julie Paul and Rebecca Jolotta were heard by the jury. Emily Thorndike’s proposed-witness issue was outside the jury and remains procedure/argument, not jury evidence. Seroquel target dose stays separate from actual reported use, and patient-reported effects remain attributed.

Trial Day 12

Witnesses: Trooper Dan Lawler; Latiesha Dukes; Cameron Daley; Dr. Renee Stonebridge; Dr. Barbara Olson. Medication containers/pill counts establish inventory, not ingestion; psychiatric/intrusive-thought testimony, custodial observation, neuropathology, and cause-of-death/autopsy testimony remain distinct.

Source note: terminal Olson examination/adjournment segment requires source cross-check.

Trial Day 13

Witnesses: Kyle Pavao; Timothy Chiappini; Joshua McKelligan. Digital artifacts do not automatically establish user identity or intent. Medication/psychiatric searches preserve timing without proving symptom, diagnosis, ingestion, motive, fabrication, or psychosis.

Trial Day 14

Commonwealth evidence closed; Rule 25 argument occurred outside the jury; the defense case began. Ian Whiffin’s extraction evidence retains attribution limits; Paula Musgrove’s collateral harm-thought report does not itself establish intent, plan, command voice, or psychosis; Dr. Michael Volfovich’s injury testimony did not establish suicidal intent.

Trial Day 15

Defense: Susan Clancy; Dr. Donald Condie; Dr. Elisabeth Laposata; Dr. Paul Zeizel. Collateral medication concerns remain attributed; retrospective expert interpretation does not upgrade self-report or medication-causation claims; physical-injury mechanism remains separate from psychiatric intent.

Source note: Zeizel call-date wording is internally inconsistent and requires authoritative AV/certified-source verification.

Trial Day 16

Dr. Paul Zeizel continued before the jury. Emily Thorndike’s voir dire occurred outside the jury and is not jury evidence. The working source has broadcast/commentary contamination and remains normalization-required.

Trial Day 17

Sheila Cavanaugh testified for the defense; preliminary charge proceedings occurred outside the jury. Her later testimony about post-event voice reports and the absence of voice/content from contemporaneous Brigham notes must both remain visible. Note omission limits documentary corroboration but does not prove the conversations did not occur.

Trial Day 18

Dr. Phillip Resnick testified for the defense; the defense rested; Dr. Avram Mack began Commonwealth rebuttal. Judge Sullivan’s limiting instruction controls evaluator self-report: statements were not admitted as proof of underlying facts, premeditation, extreme atrocity/cruelty, or specific intent, but as bases for mental-condition opinions.

Trial Day 19

Dr. Mack continued and Dr. Kirk Heilbrun began Commonwealth rebuttal. Heilbrun’s diagnosis, testing, voice-version analysis, clinical interpretation, and intrusive-thought alternative remain expert interpretation of retrospective self-report. A religion segment was struck and the jury was instructed not to consider it.

Trial Day 20

Dr. Heilbrun continued and Dr. Gregory Saathoff began Commonwealth rebuttal. Heilbrun opined criminal responsibility; his genuine-command-hallucination hypothetical answer remained conditional. Saathoff’s analysis relied on later interviews, records, and collateral and remains expert interpretation.

Trial Day 21

The existing canonical structured record supplies the proceeding date. Dr. Gregory Saathoff completed Commonwealth rebuttal. He opined mental disease/defect, Bipolar II as the best fit, and separately criminal responsibility. Voice analysis remains primarily later Lindsay self-report plus records/collateral; atypical-pattern opinion does not prove fabrication. The Commonwealth rested and the evidentiary phase closed.

Source note: consequential quotes/timestamps remain subject to AV cross-check.

Trial Day 22

This was not a witness-evidence day. Defense and Commonwealth closings were attorney argument, not evidence; Judge William Sullivan’s instructions were law. The Commonwealth retained the beyond-a-reasonable-doubt burden on criminal responsibility. Evaluator self-report remained limited-purpose, verdict forms were separated by child, the jury was reduced to 12 plus alternates, and submission began deliberations.

Source note: exact verdict-slip wording, alternate/seat mapping, and wall-clock submission time require source cross-check. Elapsed media timestamps are never converted into wall-clock time.

Deliberation Day 1

Jury deliberations began after submission. Approximately 3.5 hours were reported. No verdict.

Deliberation Day 2

Approximately seven hours were reported. No verdict. The jury requested prescription-pill exhibits and the blood-stained knife; reports state the items were provided. Exact jury-note/request wording remains unresolved.

Deliberation Day 3

Cumulative deliberations were reported at about 17 hours. No verdict. The jury requested dismissal for the evening; exact timing/communication wording remains source-bounded.

Deliberation Day 4

Jury note: “After many hours of deliberation, we are unable to come to a unanimous decision.” Judge Sullivan did not declare a mistrial and directed continued deliberation. The day ended with more than 23 cumulative hours and no verdict.

Deliberation Day 5

The jury resumed after the prior deadlock notice. No verdict or mistrial is added to this record unless verified by subsequent court action.

Final disposition

No verdict was returned before the mistrial was formally declared. Any verified final disposition will remain separately stated for Cora, Dawson, and Callan. No outcome is pre-populated from commentary, analysis, or inference.